Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide, the active ingredient in Mounjaro, is associated with an increased risk of gallbladder problems, including gallstones and gallbladder inflammation. This is a recognised pattern with GLP-1 and dual-agonist medicines, linked partly to rapid weight loss and partly to how these medicines affect the digestive system. It is not common, but it is documented in the clinical evidence and in the NHS patient information for tirzepatide. Understanding the signs matters, because gallbladder symptoms can escalate quickly and are easy to dismiss as ordinary indigestion. Tirzepatide is a prescription-only medicine: a GPhC-registered prescriber assesses your full medical history, including any gallbladder history, before treatment is recommended.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The gallbladder stores bile, which the liver produces to help digest fat. When you eat, the gallbladder contracts and releases bile into the small intestine. GLP-1 receptor agonists (and tirzepatide activates both GLP-1 and GIP receptors) slow gastric emptying and reduce the frequency and strength of gallbladder contractions. Less movement means bile sits in the gallbladder for longer, becoming more concentrated and more likely to form crystals or stones.
Rapid weight loss compounds this. As fat breaks down quickly, the liver secretes more cholesterol into bile, and the combination of high cholesterol content and sluggish gallbladder emptying is a known recipe for gallstone formation. This is not unique to tirzepatide (it happens with low-calorie diets and bariatric surgery too) but the speed at which tirzepatide can produce weight loss makes the mechanism relevant. You can read a more detailed breakdown on our page on how Mounjaro affects the gallbladder.
There is a common misconception worth addressing: some people assume that because nausea is a frequent side effect of tirzepatide, any upper-abdominal discomfort is just the medicine settling in. That is sometimes true. But gallbladder pain on Mounjaro has a different character, sharper, more localised to the right side, often triggered by fatty food, and it does not belong in the category of things to ride out. If the discomfort is new, right-sided, or severe, it warrants proper assessment, not reassurance from a forum.
The SURMOUNT-1 trial, which randomised 2,539 adults with obesity over 72 weeks, reported gallbladder-related events as a documented adverse event category. The Mounjaro Summary of Product Characteristics on the eMC lists cholecystitis and cholelithiasis (gallstones) as known side effects, and our dedicated page on Mounjaro and the gallbladder explains what these mean for people considering or already on treatment. Your prescriber should know about any existing gallbladder history before treatment begins.
Most gallbladder problems start as a dull ache or cramping sensation under the right ribcage, often appearing after a fatty meal. That alone is not an emergency, though it is a reason to speak to a clinician soon. The symptoms that need same-day or emergency medical attention are different in character.
Seek urgent help if you experience severe pain in the upper-right or centre of the abdomen that does not ease within a few hours, particularly if it radiates to your right shoulder or back. Vomiting alongside the pain, a fever, or yellowing of the skin or whites of the eyes (jaundice) all point to serious gallbladder or bile duct involvement and require emergency assessment. Acute cholecystitis (infection and inflammation of the gallbladder) can become dangerous if left untreated.
If you are on tirzepatide and develop any of these symptoms, stop eating, seek medical help promptly, and tell the clinician you are taking tirzepatide. You can also report any suspected side effect through the MHRA's Yellow Card scheme, which helps regulators track real-world safety signals for medicines like tirzepatide that carry a Black Triangle designation, meaning enhanced monitoring is ongoing.
For a broader picture of what side effects are reported with this medicine, our Mounjaro side effects guide covers the full profile including the more common gastrointestinal effects that can overlap with gallbladder symptoms.
Having had a cholecystectomy (surgical removal of the gallbladder) does not automatically rule out tirzepatide. Without a gallbladder, bile flows continuously from the liver into the small intestine rather than being stored and released in controlled amounts. This changes digestion, particularly of fatty foods, but it does not introduce a new major risk from tirzepatide's gallbladder mechanism because there is no gallbladder left to form stones or become inflamed.
That said, the picture is not entirely straightforward. People who have had their gallbladder removed can still experience bile duct stones (choledocholithiasis) in rare cases, and the ongoing digestive changes can interact with the gastric-slowing effect of tirzepatide, sometimes amplifying loose stools or digestive discomfort. These are reasons for a careful prescriber conversation, not reasons to assume tirzepatide is unsuitable.
Our page on tirzepatide with no gallbladder covers this situation in more detail, including what a prescriber typically considers when reviewing someone who has already had surgery. If you have specific questions about your history, whether Mounjaro is suitable after cholecystectomy is a question our prescribers address during the consultation itself, looking at the full clinical picture rather than applying a blanket rule.
At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber, a real clinician reads your answers before any treatment is approved. Your gallbladder history, including any prior episodes of gallstones, cholecystitis, or removal surgery, is part of what that review covers. The prescriber weighs your medical history against the known risk profile documented in sources including the NHS England guidance on weight management injections.
If tirzepatide is appropriate, the prescriber can discuss what to watch for and when to act. If there are factors that warrant further assessment before starting, you will be told clearly. Transfer patients and those requesting dose increases go through the same clinical review process, no step is skipped. You can find out more about the full Mounjaro treatment pathway or explore all the weight-loss treatments we offer if you want to compare options before booking. Our clinical team page gives more background on how prescribing oversight works at nume.
If you have concerns or want to ask something specific before starting a consultation, the FAQs cover many common questions, or you can reach the team directly through our contact page. Start your free consultation whenever you are ready, the prescriber will work through your history with you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.